Finance

Beta
Lists
4570:TYO
Immuno-Biological Laboratories Co., Ltd.
¥917.00
-0.11%
(-1.00) 1D
Jun 12, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4570...
Open
¥928
High
¥933
Low
¥904
Mkt. cap
8.54B
Avg. vol.
130.85K
Volume
55.40K
P/E ratio
25.96
52-wk high
¥3,820
52-wk low
¥464
EPS
¥35
Shares outstanding
8.42M
No. of employees
58
Open
¥928
High
¥933
Low
¥904
Mkt. cap
8.54B
Avg. vol.
130.85K
Volume
55.40K
P/E ratio
25.96
52-wk high
¥3,820
52-wk low
¥464
EPS
¥35
Shares outstanding
8.42M
No. of employees
58
News stories
From sources across the web
About Immuno-Biological Laboratories Co., Ltd.
CEO-
Employees58
FoundedSep 9, 1982
Headquarters-
SectorHealth care
Websiteibl-japan.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
211.00M
274.00M
257.00M
262.00M
Cost of goods sold
60.00M
85.00M
65.00M
88.00M
Cost of revenue
60.00M
85.00M
65.00M
88.00M
Research and development expenses
-
-
-
120.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97.00M
101.00M
110.00M
-9.00M
Operating expense
97.00M
101.00M
110.00M
117.00M
Total operating expenses
157.00M
186.00M
175.00M
205.00M
Operating income
54.00M
88.00M
82.00M
57.00M
Other non operating income
5.00M
2.00M
1.00M
6.00M
EBT including unusual items
57.00M
92.00M
87.00M
65.00M
EBT excluding unusual items
57.00M
92.00M
87.00M
65.00M
Income tax expense
-3.00M
11.00M
-20.00M
-16.00M
Effective tax rate
-5.26%
11.96%
-22.99%
-24.62%
Other operating expenses
-
-
-
-
Net income
60.00M
81.00M
107.00M
81.00M
Net profit margin
28.44%
29.56%
41.63%
30.92%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
1.00M
Interest expense
-
-
-1.00M
-
Net interest expenses
-
-
-1.00M
1.00M
Depreciation and amortization charges
-
-
-
6.00M
EBITDA
57.75M
92.00M
85.75M
61.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer